Lawsuits Allege Byetta Can Cause Pancreatic Cancer

Last Updated on June 26, 2017

Investigation Complete

Comments |

At A Glance

This Alert Affects
Patients who developed pancreatic cancer after using Byetta (exenatide).
What Is Byetta?
Byetta is a twice-daily injectable drug used to treat Type 2 diabetes. It belongs to a group of drugs known as incretin mimetics.
Amylin Pharmaceuticals and former partner company Eli Lilly and Company.
FDA Warning
In 2013, the FDA announced that it would be investigating the safety of incretin mimetics after a study found that these drugs may cause pre-cancerous cellular changes in the pancreas. Previously, the FDA warned that there may be a link between Byetta and pancreatitis (inflammation of the pancreas), which may be a symptom of pancreatic cancer.
Type of Lawsuit
Mass Tort